The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey

Clinical and Experimental Rheumatology

Volumn 28, Issue 4 SUPPL. 60, 2010, Pages

  Seyahi, Emire ^a   Tahir Turanli, Eda ^b   Mangan, Mehmet Serhat ^a   Çelikyapi, Gökçe ^b   Oktay, Veysel ^c   Çevirgen, Dilşen ^a   Kuzuoǧlu, Duygu ^b   Özoǧlu, Şuşan ^d   Yazici, Hasan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Aramyan Uncuyan Primary School   (Turkey)

Author keywords

Armenian; Beh et's syndrome; Familial mediterranean fever; HLA B51; MEFV gene mutations; Prevalence study

Indexed keywords

GENOMIC DNA; HLA B51 ANTIGEN;

ADOLESCENT; ADULT; ARMENIA; ARTICLE; BEHCET DISEASE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC GROUP; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE MUTATION; GENETIC LOAD; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; MEFV GENE; PARENT; POPULATION RESEARCH; PREVALENCE; PRIMARY SCHOOL; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; TURKEY (REPUBLIC);

ADOLESCENT; ARMENIA; BEHCET SYNDROME; CASE-CONTROL STUDIES; CHILD; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HLA-B ANTIGENS; HUMANS; MALE; MUTATION; PREVALENCE; QUESTIONNAIRES; TURKEY;

EID: 78049405733     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. AZIZLERLI G, KÖSE AA, SARICA R et al.: Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003; 42: 803-6.
2. NISHIURA K, KOTAKE S, ICHIISHI A, MATSUDA H: Familial occurrence of Behçet's disease. Jpn J Ophthalmol 1996; 40: 255-9.
3. GUL A, INANC M, OCAL L, ARAL O, KONICE M: Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 2000; 59: 622-5.
4. FRESKO I, SOY M, HAMURYUDAN V et al.: Genetic anticipation in Behçet's syndrome. Ann Rheum Dis 1998; 57: 45-8.
5. MOLINARI N, KONE PAUT I, MANNA R, DEMAILLE J, DAURES JP, TOUITOU I: Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet A 2003; 122: 115-8.
6. VERITY DH, MARR JE, OHNO S, WALLACE GR, STANFORD MR: Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999; 54: 213-20.
7. HIROHATA T, KURATSUNE M, NOMURA A, JIMI S: Prevalence of Behçet's syndrome in Hawaii with particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med J 1975; 34: 244-6.
8. ZOUBOULIS CC, KÖTTER I, DJAWARI D et al.: Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-22.
9. THE INTERNATIONAL FMF CONSORTIUM: Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
10. THE FRENCH FMF CONSORTIUM: A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
11. ROGERS DB, SHOHAT M, PETERSEN GM et al.: Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet 1989; 34: 168-72.
12. CAZENEUVE C, SARKISIAN T, PÊCHEUX C et al.: MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999; 65: 88-97.
13. SARKISIAN T, AJRAPETYAN H, SHAHSUVARYAN G: Molecular study of FMF patients in Armenia. Curr Drug Targets Inflamm Allergy 2005; 4: 113-6.
14. TOUITOU I: The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473-83.
15. BERNOT A, DA SILVA C, PETIT JL et al.: Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 1998; 7: 1317-25.
16. YAZICI H, BIYIKLI M, VAN DER LINDEN S, SCHOUTEN HJ: The 'zero patient' design to compare the prevalences of rare diseases. Rheumatology (Oxford) 2001; 40: 121-2.
17. YURDAKUL S, GUNAYDIN I, TUZUN Y et al.: The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol 1988; 15: 820-2.
18. IDIL A, GURLER A, BOYVAT A et al.: The prevalence of Behçet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 2002; 9: 325-31.
19. DEMIRHINDI O, YAZICI H, BINYILDIZ P et al.: The prevalence of Behçet's disease in Fener village (Silivri, Istanbul) and its surroundings [in Turkish]. Cerrahapasa Tip Fak Derg 1981; 12: 509-14.
20. CAKIR N, DERVIS E, BENIAN O et al.: Prevalence of Behçet's disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S53-5.
21. COSGUN S, CELIK S, MELIKOGLU M et al.: Prevalence of Behçet's syndrome and rheumatoid arthritis among hospital workers. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S85.
22. MAHR A, BELARBI L, WECHSLER B et al.: Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008; 58: 3951-9.
23. KRAUSE I, YANKEVICH A, FRASER A et al.: Prevalence and clinical aspects of Behçet's disease in the north of Israel. Clin Rheumatol 2007; 26: 555-60.
24. SAMUELS J, AKSENTIJEVICH I, TOROSYAN Y et al.: Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore).1998; 77: 268-97.
25. SALEHZADEH F, JAHANGIRI S, EMAMI D, EMAMI D, SHIARI R: Familial Mediterranean fever in Iranian children. First report from Iran. Clin Exp Rheumatol 2010; 28: 287.
26. KARASNEH J, GÜL A, OLLIER WE, SILMAN AJ, WORTHINGTON J: Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 2005; 52: 1836-42.
27. GÜL A, UYAR FA, INANÇ M et al.: A weak association of HLA-B*2702 with Behçet's disease. Genes Immun 2002; 3: 368-72.
28. YAZICI H, AKOKAN G, YALGIN B, MUFTUOGLU A: A high prevalence of HLA-B5 in Behçet's disease. Clin Exp Immunol 1977; 30: 259-61.
29. KISACIK B, YILDIRIM B, TASLIYURT T et al.: Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study. Rheumatol Int 2009; 29: 1307-9.
30. ONEN F, SUMER H, TURKAY S, AKYUREK O, TUNCA M, OZDOGAN H: Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S31-3.
31. DINC A, PAY S, TURAN M, SIMSEK I: Prevalence of familial Mediterranean fever young Turkish men. Clin Exp Rheumatol 2000; 18: 292.
32. OZEN S, KARAASLAN Y, OZDEMIR O et al.: Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1998; 25: 2445-9.
33. COBANKARA V, FIDAN G, TÜRK T, ZENCIR M, COLAKOGLU M, OZEN S: The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S27-30.
34. ALPSOY E, YILMAZ E, COŞKUN M, SAVAŞ A, YEǦIN O: HLA antigens and linkage disequilibrium patterns in Turkish Behçet's patients. J Dermatol 1998; 25: 158-62.
35. NERSISYAN VM, MARTIROSYAN IG, MUSAELYAN NO, MELIKSETYAN NO: Distribution of HLA Antigens in the Armenian Population of Nagornyi Karabakh. Russian Journal of Genetics 2002; 38: 843-6.
36. LI K, ZHAO M, HOU S, DU L, KIJLSTRA A, YANG P: Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations. Mol Vis 2008; 14: 2136-42.
37. MIZUKI N, INOKO H, SUGIMURA K et al.: RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease. Invest Ophthalmol Vis Sci 1992; 33: 3084-90.
38. BEN DHIFALLAH I, LACHHEB J, HOUMAN H, HAMZAOUI K: Toll-like-receptor gene polymorphisms in a Tunisian population with Behçet's disease. Clin Exp Rheumatol 2009; 27 (Suppl. 53): S58-62.
39. GUNESACAR R, ERKEN E, BOZKURT B et al.: Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behçet's disease. Int J Immunogenet 2007; 34: 45-9.
40. WALLACE GR, KONDEATIS E, VAUGHAN RW et al.: IL-10 genotype analysis in patients with Behçet's disease. Hum Immunol 2007; 68: 122-7.
41. BARANATHAN V, STANFORD MR, VAUGHAN RW et al.: The association of the PTPN22 620W polymorphism with Behçet's disease. Ann Rheum Dis 2007; 66: 1531-3.
42. KARASNEH JA, HAJEER AH, SILMAN A, WORTHINGTON J, OLLIER WE, GÜL A: Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behçet's disease. Rheumatology (Oxford). 2005; 44: 614-7.
43. JANG WC, NAM YH, AHN YC et al.: Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int 2008; 29: 173-8.
44. OZEN S: Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 2009; 27 (Suppl. 53): S29-31.
45. KOCA SS, ETEM EO, ISIK B et al.: Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis. Joint Bone Spine 2010; 77: 32-5.
46. YIGIT S, BAGCI H, OZKAYA O, OZDAMAR K, CENGIZ K, AKPOLAT T: MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected]. J Rheumatol 2008; 35: 106-13.
47. YILMAZ E, OZEN S, BALCI B et al.: Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9: 553-5.
48. LACHMANN HJ, SENGÜL B, YAVUZŞEN TU et al.: Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-50.
49. SACKS JJ, HARROLD LR, HELMICK CG, GURWITZ JH, EMANI S, YOOD RA: Validation of a surveillance case definition for arthritis. J Rheumatol 2005: 32: 340-7.
50. BOMBARD JM, POWELL KE, MARTIN LM, HELMICK CG, WILSON WH: Validity and reliability of self-reported arthritis: Georgia senior centers, 2000-2001. Am J Prev Med 2005; 28: 251-8.
51. HELMICK CG, FELSON DT, LAWRENCE RC et al.; NATIONAL ARTHRITIS DATA WORKGROUP: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58: 15-25.
52. KURAL-SEYAHI E, FRESKO I, SEYAHI N et al.: The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.
53. GUL A, HAJEER AH, WORTHINGTON J, BARRETT JH, OLLIER WE, SILMAN AJ: Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44: 239-40.
54. BEN-CHETRIT E, TOUITOU I: Familial Mediterranean Fever in the world. Arthritis Rheum 2009; 61: 1447-53.